Abstract：Insulin-like growth factor-1 (IGF-1) is a peptide hormone composed of 70 amino acids. Clinical studies have found that IGF-1 was closely related to endocrine diseases, cardio-cerebrovascular diseases, cancer tumors, diseases related to brain and nervous system, skin diseases, liver diseases and other diseases. IGF-1 was also found to play an important role in research of COVID-19. Therefore, the changes of serum IGF-1 content can be accurately detected as one of the auxiliary diagnostic indicators of related diseases. At present, the clinical detection methods for IGF-1 mainly include immunological analysis methods based on antigen-antibody specific binding and analysis methods based on mass spectrometry. These methods have different detection characteristics and different measurement accuracy. The relevant research progress of IGF-1 is reviewed, the functional role of IGF-1 in clinical detection and application are summarized, and the characteristics and application scenarios of its detection methods are discussed, the suggestions for further improving the detection ability of IGF-1 are also put forward.
Xie Q, Li J N. Research Progress of Insulin-Like Growth Factor-1 Derivatives［J］. Journal of Jianghan University (Natural Science Edition), 2019, 47: 555-562.
Yu L D, Shen G. The relationship of insulin-like growth factor and cutaneous tumor［J］. Journal of Clinical Dermatology, 2017, 46: 215-217.
Salmon W D, Daughaday W H. A hormonally controlled serum factor which stimulates sulfate incorpation by cartilage invitro［J］. Journal of Laboratory and Clinical Medicine, 1957, 49(6): 825-836.
Zou X L, Ye R R, Wang Y, et al. Insulin like growth factor-1 and its receptors in cancer［J］. Chongqing Medicine, 2018, 47: 2474-2476.
［1］
Mueller P L, Pritchett C E, Wiechman T N, et al. Antidepressant-like effects of insulin and IGF-1 are mediated by IGF-1 receptors in the brain［J］. Brain Research Bulletin, 2018, 143: 27-35.
Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II［J］. Proc Natl Acad Sci U S A, 1976, 73(7): 2365-9.
［6］
Tuncel D, Tolun F I, Toru I. Serum Insulin-Like Growth Factor-1 and Nitric Oxide Levels in Parkinsons Disease［J］. Mediators of Inflammation, 2009, doi:10.1155/2009/132464.
［7］
Yakar S, Isaksson O. Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models［J］. Growth Hormone & Igf Research, 2016, 28: 26-42.
Liao M, Yin Q, Liang J Y, et al. Correlation Studies of Insulin-like Growth Factor Binding Protein Related Protein 1 and Type 2 Diabetes Insulin Resistance［J］. Diabetes New World, 2017, 20: 17-19.
［9］
Rauskolb S, Dombert B, Sendtner M. Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis［J］. Neurobiology of Disease, 2017, 97: 103-113.
Li J B, Wang C Y, Chen J W, et al. Insulin like growth factor-1 gene expression abnormality and pathologic changes of nervous electrophysiology and peripheral nerves in experimental diabetic rats［J］. Chinese Journal of Clinical Rehabilitation, 2004,8(6): 1168-1170.
Guo H L, Yang Y, Geng Z P, et al. The change of insulin like growth factor 1 in the patients with diabetic neuropathy［J］. Chinese Journal of Nervous and Mental Diseases, 1999, 25(1): 11-13.
Liu X G, Xu M M, Chen P J, et al. The prospect and related mechanism of insulin-like growth factor-1 in the treatment of skeletal muscle injury［J］. Chemistry of Life, 2016, 36: 496-502.
［15］
Kordowitzki P, Krajnik K, Skowronska A, et al. Pleiotropic Effects of IGF1 on the Oocyte［J］. Cells, 2022, 11(10): 1-7.
Sadaba M C, Martin-Estal I, Puche J E, et al. Insulin-like growth factor 1 (IGF-1) therapy: Mitochondrial dysfunction and diseases［J］. Biochimica Et Biophysica Acta-Molecular Basis of Disease, 2016, 1862(7): 1267-1278.
Gatti R, De Palo CD E F, Antonelli G, et al. IGF-I/IGFBP system: Metabolism outline and physical exercise［J］. Journal of Endocrinological Investigation, 2012, 35(7): 699-707.
［14］
Aguirre G A, Rodriguez De Ita J, De La Garza R G, et al. Insulin-like growth factor-1 deficiency and metabolic syndrome［J］. Journal of Translational Medicine, 2016, 14(3): 1-23.
［17］
Sato A, Sarentonglaga B, Ogata K, et al. Effects of insulin-like growth factor-1 on the in vitro maturation of canine oocytes［J］. Journal of Reproduction and Development, 2018, 64(1): 83-88.
［18］
Shiomi S N, Komatsu K, Wang J, et al. Regulation of secondary follicle growth by theca cells and insulin-like growth factor 1［J］. Journal of Reproduction and Development, 2015, 61(3): 161-168.
Vella V, Malaguarnera R, Nicolosi M L, et al. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells［J］. Oncotarget, 2017, 8(26): 43248-43270.
Kaya A, Sagirkaya H, Misirlioglu M, et al. Leptin and IGF-I improve bovine embryo quality in vitro［J］. Animal Reproduction, 2017, 14(4): 1151-1160.
Su Y, Xu J J, Li N N, et al. Progress in the expression of insulin-like growth factor-1 in renal cell carcinoma［J］. China Medical Herald, 2019, 16: 27-29.
［26］
Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease［J］. Growth Hormone & IGF Research, 2003, 13(4): 113-170.
Yu X, Zheng J Y, Cai T F, et al. Insulin-like growth factor 1 and heart failure［J］. Chinese Journal of Arteriosclerosis, 2019, 27: 819-822.
［32］
Al-Delaimy W K, Von Muhlen D, Barrett-Connor E. Insulinlike Growth Factor-1, Insulinlike Growth Factor Binding Protein-1, and Cognitive Function in Older Men and Women［J］. Journal of the American Geriatrics Society, 2009, 57(8): 1441-1446.
［34］
Tumati S, Burger H, Martens S, et al. Association between Cognition and Serum Insulin-Like Growth Factor-1 in Middle-Aged & Older Men: An 8 Year Follow-Up Study［J］. Plos One, 2016, 11(4): 1-12.
Kang X P, Long F, Xue Q, et al. Serological indexes and peripheral blood immune index detection in patients with alopecia areata and its correlation with hair loss area［J］. Journal of Hainan Medical University, 2015, 21: 134-136.
Zhao M, Liu Z, Shao F, et al. Communication Pattern Changes Along With Declined IGF1 of Immune Cells in COVID-19 Patients During Disease Progression［J］. Frontiers in Immunology, 2022, 12: 1-14.
［45］
Coppieters G, Judak P, Van Haecke N, et al. A high-throughput assay for the quantification of intact Insulin-like Growth Factor I in human serum using online SPE-LC-HRMS［J］. Clinica Chimica Acta, 2020, 510: 391-399.
［46］
Cao B, Peng Y, Song W, et al. Pediatric Continuous Reference Intervals of Serum Insulin-like Growth Factor 1 Levels in a Healthy Chinese Children Population-Based on PRINCE Study［J］. Endocrine Practice, 2022, 28(7): 696-702.
Deng Q, Chen Y Q, Wang J J, et al. Changes of Serum IGF-1, IGFBP-3, 25(OH)D and Cortisol in Children with Idiopathic Short Stature before and after Treatment and Their Correlation with Physical Development and Bone Age［J］. Progress in Modern Biomedicine, 2022, 22(18): 3524-3527.
［50］
Pérez-Muuzuri A, López-Suárez O, Mandiá-Rodríguez N, et al. Validation of an IGF1 Screening Method for Retinopathy of Pre-maturity［J］. Front Pediatr, 2020, 8: 1-7.
［62］
Zubarev R A, Makarov A. Orbitrap Mass Spectrometry［J］. Analytical Chemistry, 2013, 85(11): 5288-5296.
Ma J X, Zhang J W, Chen J, et al. Association of serum levels of IGF1 and MMP9 with FIGO stage of cervical cancer patients and guidance of dynamic monitoring［J］. Experimental and Laboratory Medicine, 2022, 40(1): 66-68.
［21］
Schock H, Fortner R T, Surcel H M, et al. Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control study［J］. International Journal of Cancer, 2015, 137(2): 439-447.
Huang L R, Cao C C, Wu B, et al. Insulin like growth factor-1 and its receptors in endometrial cancer［J］. Progress in Obstetrics and Gynecology, 2016, 25: 472-474.
［27］
Von Der Thuesen J H, Borensztajn K S, Moimas S, et al. IGF-1 Has Plaque-Stabilizing Effects in Atherosclerosis by Altering Vascular Smooth Muscle Cell Phenotype［J］. American Journal of Pathology, 2011, 178(2): 924-934.
［33］
Doi T, Shimada H, Makizako H, et al. Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed［J］. Neurobiology of Aging, 2015, 36(2): 942-947.
［35］
Perice L, Barzilai N, Verghese J, et al. Lower circulating insulin-like growth factor-I is associated with better cognition in females with exceptional Longevity without compromise to muscle mass and function［J］. Aging-Us, 2016, 8(10): 2414-2424.
［40］
Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19［J］. Journal of Infection, 2020, 80(6): 607-613.
［42］
Ilias I, Diamantopoulos A, Botoula E, et al. Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients［J］. Frontiers in Endocrinology, 2021, 12: 1-5.
［49］
Tang J H, Ma L L, Yu T X, et al. Insulin-like growth factor-1 as a prognostic marker in patients with acute ischemic stroke［J］. PLoS One, 2014, 9(6): 1-7.
Wang N, Fu L Y, Sui C G, et al. The correlation analysis of levels of IGF 1 and CEA,CA125,CA199,CA724 in Gastric cancer patients serum and significance in the diagnosis of gastric cancer［J］. Chinese Journal of Laboratory Diagnosis, 2021, 25(2): 194-197.
［55］
Rezaei B, Majidi N, Rahmani H, et al. Electrochemical impedimetric immunosensor for insulin like growth factor-1 using specific monoclonal antibody-nanogold modified electrode［J］. Biosensors & Bioelectronics, 2011, 26(5): 2130-2134.
Lü S P, Shang R R, Zhang J, et al. Effect of insulin-like growth factor-1 on vascular smooth muscle cells in atherosclerosis［J］. Chinese Journal of Clinicians(Electronic Edition), 2016, 10: 3425-3427.
［30］
Netchine I, Azzi S, Le Bouc Y, et al. IGF1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development［J］. Best Practice & Research Clinical Endocrinology & Metabolism, 2011, 25(1): 181-190.
［31］
Ashpole N M, Sanders J E, Hodges E L, et al. Growth hormone, insulin-like growth factor-1 and the aging brain［J］. Experimental Gerontology, 2015, 68: 76-81.
Feizollahi P, Matin S, Roghani S A, et al. Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19［J］. Inflammopharmacology, 2022, 30: 199-205.
［47］
Zhu H J, Xu Y, Gong F Y, et al. Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults［J］. Plos One, 2017, 12(10): 1-15.
Waldron J, Raymond W, Ostli-Eilertsen G, et al. Insulin-like growth factor-1 (IGF1) in systemic lupus erythematosus: relation to disease activity, organ damage and immunological findings［J］. Lupus, 2018, 27(6): 963-970.
Fang X. Expression of Serum Cry61 and IGF1 in Colorectal Cancer,and Their Clinically Diagnostic Value［J］. Chinese Journal of Coloproctology, 2020, 40(6): 1-3.
［56］
Serafin V, Aguei L, Yanez-Sedeno P, et al. Electrochemical immunosensor for the determination of insulin-like growth factor-1 using electrodes modified with carbon nanotubes-poly(pyrrole propionic acid) hybrids［J］. Biosensors & Bioelectronics, 2014, 52: 98-104.
［58］
Gu Y, Liu L, Guo J, et al. Biomolecular assembly on interdigitated electrode nanosensor for selective detection of insulin-like growth factor-1［J］. Artificial Cells Nanomedicine and Biotechnology, 2021, 49(1): 30-37.
Tao S Q, Xia R S, Li F, et al. Efficacy of 3.6% topical ALA-PDT for the treatment of severe acne vulgaris［J］. European Review for Medical and Pharmacological Sciences, 2016, 20(2): 225-231.
［43］
Hazrati E, Gholami M, Farahani R H, et al. The effect of IGF-1 plasma concentration on COVID-19 severity［J］. Microb Pathog, 2022, 164: 1-4.
Xie K J, Pan F R, Xia Y X, et al. Study on changes and correlation of insulin-like growth factor-1 and bone mineral density in Graves disease［J］. Chinese Journal of Immunology, 2004(6): 433-434.
［59］
Suzuki S, Morimoto S, Fujishiro M, et al. Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis［J］. Autoimmunity, 2015, 48(4): 251-258.
［60］
Small B C, Peterson B C. Establishment of a time-resolved fluoroimmunoassay for measuring plasma insulin-like growth factor I (IGF-I) in fish: effect of fasting on plasma concentrations and tissue mRNA expression of IGF-I and growth hormone (GH) in channel catfish (Ictalurus punctatus)［J］. Domestic Animal Endocrinology, 2005, 28(2): 202-215.
［63］
Krastins B, Prakash A, Sarracino D A, et al. Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum［J］. Clinical Biochemistry, 2013, 46(6): 399-410.
［64］
Niederkofler E E, Phillips D A, Krastins B, et al. Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1［J］. PLoS One, 2013, 8(11): 1-6.
［66］
Bystrom C E, Sheng S, Clarke N J. Narrow Mass Extraction of Time-of-Flight Data for Quantitative Analysis of Proteins: Determination of Insulin-Like Growth Factor-1［J］. Analytical Chemistry, 2011, 83(23): 9005-9010.
［68］
Bronsema K J, Klont F, Schalk F B, et al. A quantitative LC-MS/MS method for insulin-like growth factor 1 in human plasma［J］. Clinical Chemistry and Laboratory Medicine, 2018, 56(11): 1905-1912.
［69］
Pratt M S, Van Faassen M, Remmelts N, et al. An antibody-free LC-MS/MS method for the quantification of intact insulin-like growth factors 1 and 2 in human plasma［J］. Analytical and Bioanalytical Chemistry, 2021, 413(8): 2035-2044.
［71］
Woolfitt A R, Solano M I, Williams T L, et al. Amino Acid Analysis of Peptides Using Isobaric-Tagged Isotope Dilution LC-MS/MS［J］. Analytical Chemistry, 2009, 81(10): 3979-3985.
［57］
Hong X, Hong X Y, Zhao H M, et al. Improved immunoassay for Insulin-like Growth Factor 1 detection by aminated silica nanoparticle in ELISA［J］. Process Biochemistry, 2020, 91: 282-287.
［61］
Fahrner R L, Lester P M, Blank G S, et al. Real-time control of purified product collection during chromatography of recombinant human insulin-like growth factor-I using an on-line assay［J］. Journal of Chromatography A, 1998, 827(1): 37-43.
［67］
Such-Sanmartin G, Bache N, Callesen A K, et al. Targeted mass spectrometry analysis of the proteins IGF1, IGF2, IBP2, IBP3 and A2GL by blood protein precipitation［J］. Journal of Proteomics, 2015, 113: 29-37.
Li J L, Wu L Q, Jin Y X, et al. Determination of the Mass Fraction of Pure Human Serum Albumin by HPLC-IDMS［J］. Acta Metrologica Sinica, 2016, 37(3): 328-332.
［72］
Elbert D L, Mawuenyega K G, Scott E A, et al. Stable isotope labeling tandem mass spectrometry (SILT): Integration with peptide identification and extension to data-dependent scans［J］. Journal of Proteome Research, 2008, 7(10): 4546-4556.
［73］
Furlanetto R W, Underwood L E, Vanwyk J J, et al. Estimation of somatomedin-c levels in normals and patients with pituitary disease by radioimmunoassay［J］. Journal of Clinical Investigation, 1977, 60(3): 648-657.
Tang Y X, Yang X D, Zhang X B. Research on Conversion Factors of the Certified Reference Materials on Different Chemiluminescence Immunity Platforms［J］. Acta Metrologica Sinica, 2021, 42(7): 964-970.
［77］
Ibba A, Corrias F, Guzzetti C, et al. IGF1 for the diagnosis of growth hormone deficiency in children and adolescents: a reappraisal［J］. Endocr Connect, 2020, 9(11): 1095-1102.
［65］
Oran P E, Trenchevska O, Nedelkov D, et al. Parallel Workflow for High-Throughput (>1,000 Samples/Day) Quantitative Analysis of Human Insulin-Like Growth Factor 1 Using Mass Spectrometric Immunoassay［J］. Plos One, 2014, 9(3): 1-8.
［74］
Kucera R, Topolcan O, Pecen L, et al. Reference values of IGF1, IGFBP3 and IGF1/IGFBP3 ratio in adult population in the Czech Republic［J］. Clinica Chimica Acta, 2015, 444: 271-277.
［76］
Brabant G, Von Zur Muhlen A, Wuster C, et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: Results from a multicenter study［J］. Hormone Research, 2003, 60(2): 53-60.
2023, Vol. 44 
